Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus: Evaluation of 24-h pH monitoring

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 2, 1999, Pages 155-162

  Haruma, K ^a   Mihara, M ^a   Okamoto, E ^a   Kusunoki, H ^a   Hananoki, M ^a   Tanaka, S ^a   Yoshihara, M ^a   Sumii, K ^a   Kajiyama, G ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CLINICAL ARTICLE; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MALE; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH ANTRUM; STOMACH PH;

AGED; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTRITIS, ATROPHIC; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; STOMACH NEOPLASMS; TIME FACTORS;

EID: 0033032981     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00459.x     Document Type: Article

References (45)

1. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993; 34: 888-92.
2. El-Omar ED, Penman ID, Ardill JES, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 581-691.
3. Parente F, Maconi G, Sangaletti O, Minguzzi M, Vago L, Porro GB. Behavior of acid secretion, gastrin release, serum pepsinogen I, and gastric emptying of liquids over six months from eradication of Helicobacter pylori in duodenal ulcer patients: a controlled study. Gut 1995; 37: 210-15.
4. Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343: 258-60.
5. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992; 116: 705-8.
6. Hill MJ, Hawksworth G, Tattersall G. Bacteria, nitrosamines and cancer of the stomach. Br J Cancer 1973; 28: 562-7.
7. Reed PI, Smith PLR, Haines K, House FR, Walters CL. Gastric juice N-nitrosamines in health and gastroduodenal disease. Lancet 1981; 2: 550-2.
8. Correa P. Human gastric carcinogenesis: a multistep and multi-factorial process. First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735-40.
9. Verhulst ML, Hopman WOM, Tangerman A, Jansen JBMJ. Eradication of Helicobacter pylori infection in patients with non-ulcer dyspepsia: effects on basal and bombesin-stimulated serum gastrin and gastric acid secretion. Scand J Gastroenterol 1995; 35: 968-73.
10. Yasunaga Y, Shinomura Y, Kanayama S, et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994; 35: 1571-4.
11. Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1977; 32: 664-8.
12. Tucci A, Blasco G, Paparo GF. Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. N Engl J Med 1997; 336: 957-8.
13. El-Omar E, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic acid hyposecretion. Gastroenterology 1997; 113: 15-24.
14. Haruma K, Sumii K, Inoue K, Teshima H, Kajiyama G. Endoscopic therapy in patients with inoperable early gastric cancer. Am J Gastroenterol 1990; 85: 522-6.
15. Tada M, Murakami A, Karita M, Yanai H, Okita K. Endoscopic resection of early gastric cancer. Endoscopy 1993; 25: 445-50.
16. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney System. Internal workshop On Histopathol Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
17. Talley NJ, Kost L, Haddad A, Zinsmeister A. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol 1992; 30: 3146-50.
18. Reynolds JR, Walt RP, Hardcastle JD, Clark AG, Smart HL, Langman MJS. 24-hour intragastric pH: continuous monitoring or nasogastric aspiration. Digestion 1986; 33: 219-24.
19. Savarino V, Mela GS, Scalabrini P, et al. 24-H comparison between pH values of continuous intraluminal recording and simultaneous gastric aspiration. Scand J Gastroenterol 1987; 22: 135-40.
20. Lee A, Dixon MF, Danon SJ, et al. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995; 7: 461-5.
21. Uemura N, Oomoto Y, Mukai T, et al. Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients. Aliment Pharmacol Ther 1997; 11: 793-800.
22. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192-9.
23. Marshall BJ, Amstrong JA, McGechi DB, Glaney RJ. Attempt to fulfill Koch's postulates for pyloric campylobacter. Med J Aust 1985; 142: 436-9.
24. Graham DY, Alpert LC, Smith JL, Yoshimura HH. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 1988; 83: 974-80.
25. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology 1996; 110: 926-38.
26. Wyllie JH, Limbosch JM, Nyhus LM. Inhibition of gastric acid secretion by bacterial lipopolysaccharide. Nature 1967; 215: 879(Letter).
27. Baume PE, Nicholls A, Baxter CH. Inhibition of gastric acid secretion by purified bacterial lipopolysaccharide. Nature 1967; 215: 59-60.
28. Beil W, Birkholz C, Wagner S, Sewing KF. Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H+/K(+)-ATPase. Gut 1994; 35: 1176-80.
29. Hoffman JS, King WW, Fox JG, Janik D, Cave DR. Rabbit and ferret parietal cell inhibition by Helicobacter pylori species. Dig Dis Sci 1995; 40: 147-52.
30. Wallace JL, Cucala M, Mugridge K, Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991; 262: G559-64.
31. Kondo S, Shinomura Y, Kanayama S, et al. Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am J Physiol 1994; 267: G966-71.
32. Smith JTL, Pounder RE, Nwokolo CU, et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990; 31: 522-5.
33. Wagner S, Gladziwa U, Haruma K, Varrentrapp M, Gebel M. Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer. Gut 1992; 33: 1024-8.
34. Katelaris PH, Scow F, Lin BPC, Napoli J, Ngu MC, Jones DB. Effect of age, Helicobacter pylori infection, and gastritis with atrophy, on serum gastrin and gastric acid secretion in healthy men. Gut 1993; 34: 1032-7.
35. El-Omar E, Penman ID, Ardill JES, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology, 1995: 681-91.
36. Haruma K, Kawaguchi H, Yoshihara M, et al. Relationship between Helicobacter pylori infection and gastric acid secretion in young healthy subjects. J Clin Gastroenterol 1994; 19: 20-2.
37. Gisbert JP, Boixeda D, Vila T, de Rafael L, Redondo C, de Argila CM. Basal and stimulated gastrin levels and gastric acid output five months after therapy for Helicobacter pylori eradication in duodenal ulcer patients. J Clin Gastroenterol 1996; 22: 90-5.
38. Prewett EJ, Smith JTL, Nwokolo CU, Hudson M, Sawyerr AM, Pounder RE. Eradication of Helicobacter pylori abolishes 24-hour hypergastrinemia: a prospective study in healthy subjects. Aliment Pharmacol Therap 1991; 5: 283-90.
39. Ihamäki T, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Comparison with a computer-matched family sample. Scand J Gastroenterol 1979; 14: 801-12.
40. Forbes GM, Warren JB, Glaser ME, Cullen DJ, Marshall BJ, Collins BJ. Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol 1996; 11: 670-3.
41. Ihamäki T, Kekki M, Sipponen P, Siurala M. The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scand J Gastroenterol 1985; 20: 485-91.
42. Hack HM, Fennerty MB, Sampliner R, Egbert B, Triadafilopoulos G, Parsonnet J. Reversal of intestinal metaplasia after treatment of H. pylori infection. Gastroenterology 1994; 106: A87 (Abstract).
43. Grossman MJJB, Kirsar LE, Gillespie LE. Basal and histalog-stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastroenterology 1963; 45: 14-26.
44. Haruma K, Yoshihara M, Sumii K, et al. Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma. Scand J Gastroenterol 1993; 28: 633-7.
45. Yoshihara M, Haruma K, Sumii K, et al. The relationship between gastric secretion and type of early gastric carcinoma. Hiroshima J Med Sci 1995; 44: 79-82.